Thermo Fisher Advances Gene Therapy with DeltaV Automation

Thermo Fisher

Prajakta Bhanap of Thermo Fisher Scientific discussed the company’s creation of Cellmation, a digital solution that dramatically streamlines the manufacture of cell therapies. For decades, the foundations of cancer treatment have been surgery, chemotherapy and radiation therapy. These continue to be critical mainstays of treatment, but in recent years new categories of treatment have helped transform the treatment outlook for many people with cancer.

Latest News

Emerson to Acquire Remaining Outstanding Shares of AspenTech

Emerson and Aspen Technology, Inc. today announced that they have reached an agreement under which Emerson will acquire all outstanding shares of...

Registration for Emerson Users’ Conference Now Open

Explore, network and learn at Emerson Exchange 2025, May 19-22 in San Antonio; Early bird registration discount available through April 14

Emerson Schedules First Quarter 2025 Earnings Release and Conference Call

Emerson reports its first quarter 2025 results prior to market open on Wednesday, Feb. 5. Conference call is available at...
Please enable JavaScript to use this website.